Logout
If you want to log out click in LogOut
The angiogenesis pathway is a tightly regulated biological process responsible for the formation of new blood vessels from pre-existing vasculature. This signaling network is essential for tissue growth, wound healing, embryonic development, and physiological vascular remodeling.
Under pathological conditions, dysregulated angiogenesis contributes to tumor progression, chronic inflammation, ischemic disorders, and vascular diseases.
The angiogenesis pathway integrates multiple growth factors, endothelial signaling cascades, extracellular matrix remodeling enzymes, and perivascular cell recruitment mechanisms to coordinate vascular sprouting and maturation.
Angiogenesis pathway activity can be efficiently assessed by measuring gene expression of pro-angiogenic factors, vascular regulators, and downstream signaling biomarkers.
Angiogenesis pathway biomarker list
View the genes included in our angiogenesis-related qPCR arrays.
Key angiogenic biomarkers include:
These markers reflect endothelial activation, matrix remodeling, and vessel maturation.
Sprouting angiogenesis is initiated when endothelial cells respond to angiogenic signals such as VEGF.
Key steps include:
This mechanism is predominant in tumor vascularization and wound repair.
Intussusceptive (splitting) angiogenesis occurs when existing vessels divide through the formation of intraluminal tissue pillars.
This mechanism:
VEGF is the primary pro-angiogenic driver.
VEGF binding to VEGFR-1 and VEGFR-2 activates:
VEGF signaling is a major therapeutic target in oncology.
PDGF regulates vessel maturation by recruiting pericytes and stabilizing newly formed vessels.
It ensures vascular integrity and structural organization.
FGF2 stimulates endothelial proliferation and plays a role in tissue repair and regenerative angiogenesis.
Tumors exploit the angiogenesis pathway to sustain growth and metastasis.
Tumor hypoxia induces VEGF production, leading to:
Anti-angiogenic therapies aim to disrupt this vascular supply.
Angiogenesis biomarkers are used to:
Common anti-angiogenic strategies include:
What can be analyzed?
Scientific data is only as powerful as the analysis behind it.
AnyGenes® provides a dedicated data analysis tool specifically developed for SignArrays® pathway panels.
What does it allow you to do?
Developed on Excel (compatible with 2007+), the software is user-friendly and requires no advanced bioinformatics skills.
Customize your own signaling pathways (SignArrays®) with the factors of your choice!
Simply download and complete our Personalized SignArrays® information file
and send it at
[email protected]
to initiate your project.
The angiogenesis pathway is a molecular signaling network that regulates the formation of new blood vessels from existing vasculature through coordinated activation of endothelial cells and growth factor signaling.
Angiogenesis is primarily triggered by hypoxia and growth factors such as VEGF, FGF, and PDGF, which stimulate endothelial cell migration, proliferation, and survival.
Tumors activate the angiogenesis pathway to secure oxygen and nutrient supply, promoting tumor growth, metastasis, and resistance to therapy.
Key biomarkers include VEGFA, VEGFR2, FGF2, PDGFB, ANGPT2, MMPs, and endothelial markers such as CD31.
Angiogenesis pathway activity can be analyzed by measuring expression of angiogenic growth factors, receptors, and downstream signaling genes using targeted gene expression tools such as qPCR pathway arrays.
| Signaling Pathways | Product ref | Informations |
|---|---|---|
Angiogenesis |
AN1H1 |
|
Angiogenesis | AN2H1 |
| Signaling Pathways | Product ref | Informations |
|---|---|---|
Angiogenesis | AN1M1 |
|
Angiogenesis | AN2M1 |
| Signaling Pathways | Product ref | Informations |
|---|---|---|
Angiogenesis | ******* |
Biomarker list in progress. |
| Signaling Pathways | Product ref | Informations |
|---|---|---|
Angiogenesis | ******* |
Biomarker list in progress. |
Looking for more answers? Visit our Help & FAQ section to find detailed informations about our products, services, and technical support.
1. Ma Q, et al. Role of melatonin in controlling angiogenesis under physiological and pathological conditions. Angiogenesis. (2020);23(2):91-104.
2. Huang YJ, Nan GX. Oxidative stress-induced angiogenesis. J Clin Neurosci. (2019);63:13-16.
3. Mukherjee A, et al. Recent Advancements of Nanomedicine towards Antiangiogenic Therapy in Cancer. Int J Mol Sci. (2020);21(2):455.
4. Braile M, et al. VEGF-A in Cardiomyocytes and Heart Diseases. Int J Mol Sci. (2020);21(15):5294.
5. Lee HJ, et al. Angiogenesis in Chronic Inflammatory Skin Disorders. Int J Mol Sci. 2021 Nov 7;22(21):12035.
6. Loizzi V, et al. Biological Pathways Involved in Tumor Angiogenesis and Bevacizumab Based Anti-Angiogenic Therapy with Special References to Ovarian Cancer. Int J Mol Sci. (2017)14;18(9):1967.